As 2026 unfolds, the women’s health M&A market is entering a period of renewed momentum following two years of calibration and normalization after the 2021-2022 transaction peaks. Multiple macroeconomic and structural forces are converging to support increased deal activity: stabilizing interest rates are improving acquisition financing conditions, record levels of PE dry powder are seeking deployment, improving public equity market conditions are creating a clearer path to future PE exits, and the demographic and structural fundamentals underlying women’s health demand continue to strengthen.
Read the full article: What’s Next for Women’s Health M&A in 2026 and Beyond //
Source: https://midcapadvisors.com/insights/article-16-whats-next-for-womens-health-ma-in-2026-and-beyond/